Therefore, their treatment is crucial for hampering or reducing difficulties caused by an endocrine system imbalance such as insufficient insulin secretion or response [7] and insulin resistance in obesity [8, 9] or NAFLD [10]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.